Cooper TE, Teng C, Howell M, Teixeira-Pinto A, Jaure A, Wong G. D-mannose for preventing and treating urinary tract infections. Cochrane Database Syst Rev. 2022;8:CD013608. https://doi.org/10.1002/14651858.CD013608.pub2.

Article  PubMed  Google Scholar 

Ala-Jaakkola R, Laitila A, Ouwehand AC, Lehtoranta L. Role of D-mannose in urinary tract infections–a narrative review. Nutr J. 2022;21:1–16.

Article  Google Scholar 

Mydock-McGrane LK, Cusumano ZT, Janetka JW. Mannose-derived FimH antagonists: a promising anti-virulence therapeutic strategy for urinary tract infections and Crohn’s disease. Expert Opin Ther Pat. 2016;26:175–97. https://doi.org/10.1517/13543776.2016.1131266.

Article  CAS  PubMed  Google Scholar 

Scaglione F, Musazzi UM, Minghetti P. Considerations on D-mannose mechanism of action and consequent classification of marketed healthcare products. Front Pharmacol. 2021;12: 636377.

Article  CAS  PubMed  PubMed Central  Google Scholar 

European_Community. MANUAL ON BORDERLINE AND CLASSIFICATION IN THE COMMUNITY REGULATORY FRAMEWORK FOR MEDICAL DEVICES. https://ec.europa.eu/docsroom/documents/35582. Accessed 27 Oct 2022

Capone L, Geraci A, Giovagnoni E, Marcoaldi R, Palazzino G. Elements of assessment and discernment between medical devices and medicinal products. Rapporti ISTISAN - Istituto Superiore di Sanità (2012) pp. 65.

European Commission. MDCG 2022 – 5 Guidance on borderline between medical devices and medicinal products under Regulation (EU) 2017/745 on medical devices. (2022) https://health.ec.europa.eu/system/files/2022-04/mdcg_2022-5_en_0.pdf

Leone MG. Medical devices made of substances: a new challenge. Front Drug Safety Regulat. 2022;2: 952013.

Article  Google Scholar 

Alton G, Hasilik M, Niehues R, Panneerselvam K, Etchison JR, Fana F, Freeze HH. Direct utilization of mannose for mammalian glycoprotein biosynthesis. Glycobiology. 1998;8:285–95.

Article  CAS  PubMed  Google Scholar 

Herman RH. Mannose metabolism. II. American J Clin Nutri. 1971;24:556–61.

Article  CAS  Google Scholar 

Durán JM, Cano M, Peral MJ, Ilundáin AA. D-mannose transport and metabolism in isolated enterocytes. Glycobiology. 2004;14:495–500.

Article  PubMed  Google Scholar 

Sharon N. Carbohydrates as future anti-adhesion drugs for infectious diseases. Biochim Biophys Acta. 2006;1760:527–37. https://doi.org/10.1016/j.bbagen.2005.12.008.

Article  CAS  PubMed  Google Scholar 

Sharma V, Ichikawa M, Freeze HH. Mannose metabolism: more than meets the eye. Biochem Biophys Res Commun. 2014;453:220–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Loblaw DA, Prestrud AA, Somerfield MR, Oliver TK, Brouwers MC, Nam RK, Lyman GH, Basch E. Americal Society of clinical oncology clinical practice guidelines. American Society of clinical oncology clinical practice guidelines: formal systematic review-based consensus methodology. J Clin Oncol. 2012;30:3136–40. https://doi.org/10.1200/JCO.2012.42.0489.

Article  PubMed  Google Scholar 

Lynn MR. Determination and quantification of content validity. Nurs Res. 1986;35:382–6.

Article  CAS  PubMed  Google Scholar 

Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372: n160.

Article  PubMed  PubMed Central  Google Scholar 

Tong A, Flemming K, McInnes E, Oliver S, Craig J. Enhancing transparency in reporting the synthesis of qualitative research: ENTREQ. BMC Med Res Methodol. 2012;12:1–8.

Article  Google Scholar 

France EF, Cunningham M, Ring N, Uny I, Duncan EA, Jepson RG, Maxwell M, Roberts RJ, Turley RL, Booth A. Improving reporting of meta-ethnography: the eMERGe reporting guidance. BMC Med Res Methodol. 2019;19:1–13.

Article  Google Scholar 

Official Journal of the European Union L 117 - Volume 60. (2017) https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=OJ:L:2017:117:FULL&from=EN. Accessed 23 Dec 2022

European Commission. REGULATION (EU) 2017/745 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC. (2017). https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32017R0745

DIRECTIVE 2001/83/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL OF 6 NOVEMBER 2001 ON THE COMMUNITY CODE RELATING TO MEDICINAL PRODUCTS FOR HUMAN USE. (2001) https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/directive-2001/83/ec-european-parliament-council-6-november-2001-community-code-relating-medicinal-products-human-use_en.pdf. Accessed 23 Dec 2022

European Commission (2015a). Guidance document on the demarcation between the cosmetic products directive 76/768 and the medicinal products directive2001/83 as agreed between the commission services and the competent authorities of member states. https://ec.europa.eu/docsroom/documents/13032/attachments/1/translations. Accessed 23 Dec 2022

European Union Court (2012). Judgment C-308/11–chemische fabrik kreussler and Co. GmbH v sunstar deutschland GmbH, formerly John O. Butler GmbH. https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:62011CJ0308&from=GA. Accessed 23 Dec 2022

MEDDEV 2. 1/3 rev 3. MEDICAL DEVICES: Guidance document - Borderline products, drug-delivery products and medical devices incorporating, as an integral part, an ancillary medicinal substance or an ancillary human blood derivative. http://www.meddev.info/_documents/2_1_3_rev_3-12_2009_en.pdf

Fein JE. Screening of uropathogenic Escherichia coli for expression of mannose-selective adhesins: importance of culture conditions. J Clin Microbiol. 1981;13:1088–95.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ofek I, Mosek A, Sharon N. Mannose-specific adherence of Escherichia coli freshly excreted in the urine of patients with urinary tract infections, and of isolates subcultured from the infected urine. Infect Immun. 1981;34:708–11.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Reid G, Brooks HJ. In vivo attachment of E coli to human epithelial cells. N Z Med J. 1984;97:439–42.

CAS  PubMed  Google Scholar 

Hultgren SJ, Schwan WR, Schaeffer AJ, Duncan JL. Regulation of production of type 1 pili among urinary tract isolates of Escherichia coli. Infect Immun. 1986;54:613–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hacker J, Schrettenbrunner A, Schröter G, Düvel H, Schmidt G, Goebel W. Characterization of Escherichia coli wild-type strains by means of agglutination with antisera raised against cloned P-, S-, and MS-fimbriae antigens, hemagglutination, serotyping and hemolysin production. Zentralblatt für Bakteriologie, Mikrobiologie und Hygiene Series A. 1986;261:219–31.

Article  CAS  Google Scholar 

Jones CH, Pinkner JS, Roth R, Heuser J, Nicholes AV, Abraham SN, Hultgren SJ. FimH adhesin of type 1 pili is assembled into a fibrillar tip structure in the Enterobacteriaceae. Proc Natl Acad Sci USA. 1995;92:2081–5. https://doi.org/10.1073/pnas.92.6.2081.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ronald LS, Yakovenko O, Yazvenko N, Chattopadhyay S, Aprikian P, Thomas WE, Sokurenko EV. Adaptive mutations in the signal peptide of the type 1 fimbrial adhesin of uropathogenic Escherichia coli. Proc Natl Acad Sci U S A. 2008;105:10937–42. https://doi.org/10.1073/pnas.0803158105.

Article  PubMed  PubMed Central  Google Scholar 

Chen SL, Hung CS, Pinkner JS, Walker JN, Cusumano CK, Li Z, Bouckaert J, Gordon JI, Hultgren SJ. Positive selection identifies an in vivo role for FimH during urinary tract infection in addition to mannose binding. Proc Natl Acad Sci. 2009;106:22439–44.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Scribano D, Sarshar M, Prezioso C, Lucarelli M, Angeloni A, Zagaglia C, Palamara AT, Ambrosi C. d-Mannose treatment neither affects Uropathogenic Escherichia coli Properties nor induces stable FimH Modifications. Molecules. 2020;25:316. https://doi.org/10.3390/molecules25020316.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marcon J, Schubert S, Stief CG, Magistro G. In vitro efficacy of phytotherapeutics suggested for prevention and therapy of urinary tract infections. Infection. 2019;47:937–44.

Article  PubMed  Google Scholar 

Ribić R, Meštrović T, Neuberg M, Kozina G. Proposed dual antagonist approach for the prevention and treatment of urinary tract infections caused by uropathogenic Escherichia coli. Med Hypotheses. 2019;124:17–20.

Article  PubMed  Google Scholar 

Kalas V, Pinkner JS, Hannan TJ, Hibbing ME, Dodson KW, Holehouse AS, Zhang H, Tolia NH, Gross ML, Pappu RV, et al. Evolutionary fine-tuning of conformational ensembles in FimH during host-pathogen interactions. Sci Adv. 2017;3:e1601944. https://doi.org/10.1126/sciadv.1601944.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bhomkar P, Materi W, Semenchenko V, Wishart DS. Transcriptional response of E. coli upon FimH-mediated fimbrial adhesion. Gene regulation and Syst Biol. 2010;4:GRSB-S4525.

Google Scholar 

Hatton NE, Baumann CG, Fascione MA. Developments in mannose-based treatments for Uropathogenic Escherichia coli -induced urinary tract infections. ChemBioChem. 2021;22:613–29. https://doi.org/10.1002/cbic.202000406.

Article  CAS  PubMed  Google Scholar 

Madison B, Ofek I, Clegg S, Abraham SN. Type 1 fimbrial shafts of Escherichia coli and Klebsiella pneumoniae influence sugar-binding specificities of their FimH adhesins. Infect Immun. 1994;62:843–8. https://doi.org/10.1128/iai.62.3.843-848.1994.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pak J, Pu Y, Zhang Z-T, Hasty DL, Wu X-R. Tamm-Horsfall protein binds to type 1 fimbriated Escherichia coli and prevents E. coli from binding to uroplakin Ia and Ib receptors. J Biol Chem. 2001;276:9924–30.

Article  CAS  PubMed  Google Scholar 

Schwartz DJ, Kalas V, Pinkner JS, Chen SL, Spaulding CN, Dodson KW, Hultgren SJ. Positively selected FimH residues enhance virulence during urinary tract infection by altering FimH conformation. Proc Natl Acad Sci USA. 2013;110:15530–7. https://doi.org/10.1073/pnas.1315203110.

Article  PubMed  PubMed Central  Google Scholar 

Zhou G, Mo W-J, Sebbel P, Min G, Neubert TA, Glockshuber R, Wu X-R, Sun T-T, Kong X-P. Uroplakin Ia is the urothelial receptor for uropathogenic Escherichia coli: evidence fro